Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
22:52
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

International Liver Cancer Association 15th Annual Conference

 

September 2 - 5, 2021 Virtual Conference
FAQs
   
Discussion forum - International Liver Cancer Association 15th Annual Conference
    Topic - 4. Therapy & Miscellaneous

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER
  
 Thread / Poster  Author  Replies  Last reply
Previous/Concurrent Radiation Enhanced the Efficacy of Immunotherapy in Metastatic and Recurrent Liver Cancer: A Pilot Study from the Real-world Data  Chen Bo 1      8/29/2021 4:05:00 PM  
Real-world outcomes of patients with hepatocellular carcinoma treated with transarterial radioembolization: results from CIRT, a large European prospective multi-centre observational study  Niels de Jong 1      8/23/2021 10:49:00 AM  
Identification of Regorafenib Prognostic index (REP index) via recursive partitioning analysis in Advanced Hepatocellular Carcinoma Patients Receiving systemic treatment.  Margherita Rimini 1      8/23/2021 10:49:00 AM  
A humanized Claudin-1-specific monoclonal antibody for treatment of hepatocellular carcinoma  Marion Muller 1      8/23/2021 10:49:00 AM  
Early antibiotic exposure is not detrimental to response to immune checkpoint inhibitor therapy for hepatocellular carcinoma: evidence from an observational study.  Petros Fessas 1      8/23/2021 10:49:00 AM  
Impact of metabolic syndrome and non-alcoholic fatty liver disease in outcomes and tolerance after percutaneous multibipolar radiofrequency ablation for early hepatocellular carcinoma  Thi Thu Nga Nguyen 1      8/23/2021 10:49:00 AM  
Efficacy and Safety of Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Retrospective Analysis  KyungHye Bang 1      8/23/2021 10:49:00 AM  
Free Androgen Index Levels May Influence the Trans-arterial Chemoembolization with Doxorubicin-Eluting Beads Response in Hepatocellular Carcinoma Patients: Preliminary Results.  Silvia Acosta-López 1      8/23/2021 10:49:00 AM  
Impact of previous surgery on prognosis in patients with cholangiocarcinoma under chemotherapy  Margherita Rimini 1      8/23/2021 10:49:00 AM  
Exploratory Network Meta-analyses of Selective Internal Radiation Therapy versus Sorafenib, Lenvatinib, and Atezolizumab-Bevacizumab as First-line Treatment in Subgroups of Patients with Hepatocellular Carcinoma  Richard Pollock 1      8/23/2021 10:49:00 AM  
The Number of Small Hepatocellular Carcinoma Nodules in Patients Listed for Liver Transplantation within the Alpha-Fetoprotein Score Is a Prognostic Risk Factor  Alina Pascale 1      8/23/2021 10:49:00 AM  
Progression patterns and clinical outcomes following immune checkpoint inhibition for hepatocellular carcinoma (HCC): a multi-institutional international study.  Thomas Talbot 1      8/23/2021 10:49:00 AM  
The Number of Small Hepatocellular Carcinoma Nodules in Patients Listed for Liver Transplantation within the Alpha-Fetoprotein Score Is a Prognostic Risk Factor  Alina Pascale 1      8/22/2021 11:54:00 PM  
Impact of metabolic syndrome and non-alcoholic fatty liver disease in outcomes and tolerance after percutaneous multibipolar radiofrequency ablation for early hepatocellular carcinoma  Thi Thu Nga Nguyen 1      8/22/2021 11:48:00 PM  
Progression patterns and clinical outcomes following immune checkpoint inhibition for hepatocellular carcinoma (HCC): a multi-institutional international study.  Thomas Talbot 1      8/20/2021 5:35:00 PM  
Real-world outcomes of patients with hepatocellular carcinoma treated with transarterial radioembolization: results from CIRT, a large European prospective multi-centre observational study  Niels de Jong 1      8/20/2021 2:18:00 PM  
Exploratory Network Meta-analyses of Selective Internal Radiation Therapy versus Sorafenib, Lenvatinib, and Atezolizumab-Bevacizumab as First-line Treatment in Subgroups of Patients with Hepatocellular Carcinoma  Richard Pollock 1      8/19/2021 11:40:00 AM  
       




Most viewed poster for this congress
Poster: 1
Visits: 215
Title: Temporal and Spatial Dynamics of Hepatic Stellate Cell Activation in Intrahepatic Cholangiocarcinoma
Authors: Liqin Zhu , Cheng Tian, Liyuan Li, Qingfei Pan, Yizhen Li, Wentao Yang, Li Fan, Anthony Brown, Michelle Morrison, Kaushik K. Dey, Eric J. Norris, Jun J. Yang, Jiyang Yu, Evan S. Glazer
Centre: 

Poster most viewed in this topic
Poster: 60
Visits: 83
Title: Efficacy and Safety of Lenvatinib in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Retrospective Analysis
Authors: KyungHye Bang , Changhoon Yoo, Min-Hee Ryu, Sook Ryun Park, Hyung-Don Kim, Baek-Yeol Ryoo
Centre: 


 




PosterSessionOnline
Logo Draft
 
Logo Cert